Preclinical thyroid cancer study restores CAR-T target with targeted drugs
A preclinical Mayo Clinic study found that MAPK inhibitors restored TSHR on anaplastic thyroid cancer cells and improved tumor control ...
Tag: MAPK inhibitors
POPULAR NEWS
-
Laura Esserman Wins 2026 AIM-HI Beacon Award for Breast Cancer Leadership
-
Research report: Development and psychometric validation of the hospital Security Personnel Narrative Competency Scale (HSPNCS)
-
Hairy-root perilla yields more shikonin and comparable luteolin
-
Mycoplasma pneumoniae co-infections linked to severe pediatric illness in Guangzhou